Search

everythinglearnresearchcommunity

for

Search:↓

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

Finasteride therapy reduces PSA levels and prostate size, helping diagnose prostate cancer.

BPH treatments can cause sexual side effects affecting quality of life.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

BPH treatment improved with personalized medicine, new drugs, and less invasive surgeries.

Finasteride lowers risk of urinary issues and surgery by over 50% in 4 years.

Finasteride reduces PSA levels by around 40-50% in BPH patients.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

BPH treatments are improving with personalized medicine and better surgical options.

Finasteride may reduce prostate bleeding by lowering blood vessel growth factor levels and blood vessel density in certain prostate areas.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Certain natural compounds called terpenes may help prevent prostate cancer.

Oral finasteride and dutasteride may negatively affect erectile function in rats.

The new delivery method for dutasteride is more effective and has fewer side effects.

Early balding may be a sign of future prostate problems.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

Low dose finasteride causes only small changes in PSA levels in older men with BPH.